Orally disintegrating tablets: An overview

Journal of Applied Pharmaceutical Science

Volumn 4, Issue 2, 2014, Pages 118-125

  Alǧin Yapar, Evren ^a  

^a MINISTRY OF HEALTH   (Turkey)

Author keywords

Deglutition disorders; Excipients; Orally disintegrating tablets; Patents; Taste masking

Indexed keywords

EID: 84896869666     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: 10.7324/JAPS.2014.40219     Document Type: Article

References (87)

1. Abed KK, Hussein AA, Ghareeb MM, Abdulrasool AA. Formulation and optimization of orodispersible tablets of diazepam. AAPS Pharm Sci Tech, 2010;11(1):356-361.
2. Al-Shadeedi MI, Samein LH, Shehab MA. Formulation and evaluation of carbimazole orodispersible tablet. Int J Pharm Pharmaceut Sci, 2013;5(1):232-239.
3. Ananda V, Kandarapub R, Gargc S. Preparation and evaluation of taste-masked orally disintegrating tablets of prednisolone. AJPS, 2007;2(6): 227-238.
4. Arun D, Venugopal N, Shekar L, Ramarav B, Rao JV, Karunakar K, Surendra Y. Formulation, characterization and in vitro evaluation of orodisipersible taste masking tablets of prednisolone sodium phosphate. Int J Pharm Bio Sci, 2012;2(2):30-41.
5. Aurora J, Pathak V. Oral Disintegrating Technologies: Oral Disintegrating Dosage Forms: An Overview. Drug Deliv Technol, 2005;5(3):50-54.
6. Badgujar BP, Mundada AS. The technologies used for developing orally disintegrating tablets: A review. Acta Pharm, 2011;61(2):117-139.
7. Bandari S, Mittapalli RK, Gannu R, Rao YM. Orodispersible tablets: An overview. Asian J Pharm, 2008;2:2-11.
8. Beri C, Sacher I. Development of fast disintegration tablets as oral drug delivery system-A review. Indian J Pharm Biol Res, 2013;1(3):80-99.
9. Bharath Kumar R, Vedavathi T. Formulation and evaluation of sumatriptan succinate oral disintegrating tablets and comparision of disintegrating property between super disintegrants and simple disintegrants. The Pharma Innovation, 2012;1(9):73-92.
10. Bharawaj S, Jain V, Sharma S, Jat RC, Jain S. Orally disintegrating tablets: A review. DIT, 2010;2(1):81-88.
11. Bhasin RK, Bhasin N, Ghosh PK. Advances in Formulation of Orally Disintegrating Dosage Forms: A Review Article. IGJPS, 2011;1(4):328-353.
12. Bhowmik D, Chiranjib B, Krishnakanth B, Pankaj N, Margret CR. Fast dissolving tablet: An overview. JOCPR, 2009;1(1):163-177.
13. Chowdary KPR, Aishwarya KVNR. Preparation and evaluation of fast dissolving tablets of selected drugs employing superdisintegrants. JGTPS 2014; 5(1):1392-1398.
14. Comoglu T, Dogan A, Comoglu S, Basci N. Formulation and evaluation of diclofenac potassium fast-disintegrating tablets and their clinical application in migraine patients. Drug Dev Ind Pharm, 2011; 37(3):260-267.
15. Dass S, Mazumder SA. An Updated Precise Review on Superdisintegrants. IAJPR 2013;3(6):5342-5355.
16. Deshmkh H, Chandrashekhara S, Nagesh C, Murade A, Usgaunkar S. Superdisintegrants: A Recent Investigation and Current Approach. Asian J Pharm Tech 2012;2(1):19-25.
17. Dobetti L. Fast-melting tablets: Developments and technologies. Pharm Tech, 2000;12(9):32-42.
18. Dobetti L. Fast disintegrating tablets. EP 1 058 538 B2: 2012.
19. Douroumis DD, Gryczke A, Schminke S. Development and evaluation of Cetirizine HCl taste-masked oral disintegrating tablets. AAPS Pharm Sci Tech, 2011;12(1):141-151.
20. Errolla Mahesh GB, Kiran Kumar MGA, Kiran Kumar P. Formulation and evaluation of montelukast sodium fast dissolving tablets. AJBPS, 2012; 2(14):75-82.
21. Faiz Qadri S, Padala PR, Chris Strunk J, Boust SJ. High-dose olanzapine orally disintegrating tablets for treatment-resistant psychosis. Prim Care Companion J Clin Psychiatry, 2006;8(4):244-245.
22. Fu Y, Yang S, Jeong SH, Kimura S, Park K. Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies. Crit Rev Ther Drug Carrier Syst, 2004;21(6):433-76.
23. Fujiwara K, Fukami T, Koizumi H. Disintegrating particle composition and orally rapidly disintegrating tablet. EP 2 465 539 A1:2012.
24. Gavin MacNicol B, Regimbeavon, Uexküll-Güldenband A. Orally disintegrating composition comprising mirtazapine. T 0418/09: 2013.
25. Ghosh TK, Pfister WR. 2005. Intraoral Delivery Systems: An Overview, Current Status and Future Trends. In Ghosh TK, Pfister WR, ed. Drug Delivery to the Oral Cavity: Molecules to Market. CRC Press, New York.p.1-40.
26. Green R, Hall M, Kearney P, Murray O. Fast-dispersing dosage forms containing fish gelatin. Patent WO 2000061117 A1; 2000.
27. Gondaliya RP, Arvadiya AC, Dusunge, SB, Mahajan, HS. Comparative study on effect of natural and synthetic superdisintegrants in formulation of lornoxicam orodispersible tablet. Am J PharmTech Res 2013;3(1):487-495.
28. Gupta DK, Agarwal DK, Tyagi S, Sharma RD, Gupta R, Sharma KK, Sharma PP. Natural & Synthetic Superdisintegrants in FDT: A Review. IJAR 2013;1(6):576-583.
29. Gupta S, Ahuja V, Gunjikar T, Wannerberger K. A fast dissolving pharmaceutical composition. European Patent Application EP 2552418 A2; 2013.
30. Haas PD, Koc F, Sivasligil R, Kandemir L, Ilhan SA. Mozavaptan formulations. EP 2 609 909 A1: 2013.
31. Higuchi S, Fukada H, Saito T, Tabata T. Method of producing solid preparation disintegrating in the oral cavity. European Patent EP1967211A4; 2009.
32. Hirani JJ, Rathod DA, Vadalia KR. Orally disintegrating tablets: A review. TJPR, 2009;8(2):161-172.
33. Ikeda Y, Ochiai Y. Orally disintegrating tablet. European Patent EP 2218443A1; 2011.
34. Jha AK, Chetia D. Development of natural gum based fast disintegrating tablets of glipizide. Asian J Pharm, 2012;6(4):282-288.
35. Jumaa AKF, Abdulrasool AA, Al-Dujali HA. Formulation and Clinical Evaluation of Orphenadrine citrate as a Plain Tablet. Iraqi J Pharm Sci, 2006;15(1):1-9.
36. Kawano Y, Ito A, Sasatsu M, Machida Y. Preparation of orally disintegrating tablets with taste-masking function: masking effect in granules prepared with correctives using the dry granulation method and evaluation of tablets prepared using the taste-masked granules. Yakugaku Zasshi, 2010;130(1):81-86.
37. Kavitha K, Hui BJ, Subramaniam K, Santhi K, Dhanaraj SA, Rupeshkumar M. role of superdisintegrants in the design of fast dissolving drug delivery systems-A review. IJAPR 2013;4(11):2475-2483.
38. Khairnar DA, Anantwar SP, Chaudhari CS, Shelke PA. Superdisintegrants: An emerging paradigm in orodispersible tablets. Int J Biopharmaceutics. 2014;5(2):119-128.
39. Kharade S, Bhutkar MA. Novel superdisintegrants interpolymeric chitosan-alginate complex and chitin in the formulation of orodispersible tablets. IJPRD 2013;5(5):87-94.
40. Klancke J. Dissolution testing of orally disintegrating tablets. Dissolution Technol, 2003;10(2):6-8.
41. Kumar S, Gupta SK, Sharma PK. A review on recent trends in oral drug delivery-fast dissolving formulation technology. Adv Biol Res, 2012;6(1):06-13.
42. Kumare MM, Marathe RP, Kawade RM, Ghante MH, Shendarkar GR. Design of fast dissolving tablet of atenolol using novel co-processed superdisintegrant. Asian J Pharm Clin Res 2013;6(3):81-85.
43. Leonardi D, Bombardiere ME, Salomon CJ. Effects of benznidazole:cyclodextrin complexes on the drug bioavailability upon oral administration to rats. Int J Biol Macromol, 2013;62:543-548.
44. Li H, Wang H, Wang M, Wang L. Orally disintegrating tablet and method of preparation. European Patent Application EP 1803446 A1; 2007.
45. Lim CBS, Sunderland VB, Lee YHE. Fast dissolving solid dosage form. European Patent Application EP 2493457 A1; 2010.
46. Lim CBS, Sunderland VB, Lee YHE. Fast dissolving solid dosage form. EP2493457 A1: 2012.
47. Malke S, Shidhaye S, Kadam V J. Formulation and evaluation of oxcarbazepine fast dissolve tablets. Indian J Pharm Sci, 2007;69:211-214.
48. Manivannan R. Oral disintegrating tablets: A future compaction. DIT, 2009;1(1):61-65.
49. Mezaache N, Frisbee S E, Woodall P B, Herman M R. Quick dissolve compositions and tablets based thereon. US Patent Application 20120082729:2012.
50. Mohammed A, Alhusban F, Perrie Y. A freeze-dried tablet. Patent WO 2011124876 A2; 2011.
51. Mohanachandran PS, Sindhumol PG, Kiran TS. Superdisintegrants: An overview. IJPSRR, 2011;6(1):105-109.
52. Mrudula HB, Derle DV. Mechanism of disintegrant action of polacrilin potassium: Swelling or wicking. APSB 2012;2(1):70-76.
53. Nakamura K, Ogawa T. Orally disintegrating tablet. EP 2 591 774 A1:2013.
54. Ohkouchi K, Koyama H. Quickly disintegrating solid preparations. European Patent Application EP1203580; 2002.
55. Olmez SS, Vural I, Sahin S, Ertugrul A, Capan Y. Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compression. Pharmazie, 2013;68(2):110-116.
56. Ölmez SS, Vural İ. Advantages and quality control of orally disintegrating tablets. FABAD J Pharm Sci, 2009;34:167-172.
57. Ölmez SS, Vural İ, Şahin S, Ertuǧrul A, Çapan Y. Aǧizda daǧilan tabletler II: In vitro ve in vivo deǧerlendirilmeleri. Hacettepe üniv Ecz Fak Der, 2011;31(1):59-70.
58. Pahwa R, Piplani M, Sharma PC, Kaushik D, Nanda S. Orally disintegrating tablets-Friendly to pediatrics and geriatrics. Arch Appl Sci Res, 2010;2(2):35-48.
59. Parakh SR, Gothoskar AV. A review of mouth dissolving tablet technologies. Pharm Technol, 2003;27:92-100.
60. Parkash V, Maan S, Deepika, Yadav SK, Hemlata, Jogpal V. Fast disintegrating tablets: Opportunity in drug delivery system. J Adv Pharm Technol Res, 2011;2(4):223-235.
61. Parthasaradhi RB, Khadgapathi P, Ramarao N. Fast release solid oral compositions of entecavir. WO 2013072937 A2: 2013.
62. Patel NV, Chauhan S, Aundhia C, Seth AK. Formulation and evaluation of amlodipine besylate orally disintegrating tablet. IAJPR, 2011:2(1);146-152.
63. Pfister WR, Ghosh TK. Orally Disintegrating Tablets Products, Technologies, and Development Issues. Pharm Tech, 2005;29(10):p136.
64. Pilgaonkar PS, Rustomjee MT, Gandhi AS. Taste-masked orally disintegrating tablets of memantine hydrochloride. EP 2 583 669 A1:2013.
65. Ping F, Jianping Q. Glipizide orally disintegrating tablet and preparation process thereof. Patent CN10169548;2009.
66. Prajapati BG, Ratnakar N. A review on recent patents on fast dissolving drug delivery system. Int J PharmTech Res, 2009;1(3):790-798.
67. Preethi S, Selviarun K, Jagadeesh S, Nagendre R, Prashanth Kumar MR. Oral dispersible tablet-An overview. Int J Inv Pharm Sci, 2013;1(5):438-447.
68. Priyanka S and Vandana S. A review article on: Superdisintegrants. Int J Drug Res Tech 2013;3(4):76-87.
69. Ram DK, Vidyanand P, Shekhar V, Kumar PA, Pramod D. A review on mouth dissolving tablet techniques. IJRAP, 2011;2(1):66-74.
70. Ramtoola Z, Pabari R, Jamil A. Orodispersible tablets. US Patent Application 20120077888: 2012.
71. Rani TR, Rathore DS, Amit V. Formulation and evaluation of oral dispersible tablet containing spironolactone hydroxypropyl: β-cyclodextrin binary system. IRJP, 2012;3(4):318-323.
72. Ratnaparkhi MP, Mohanta GP, Upadhyay L. Review On: Fast Dissolving Tablet. J Pharm Res, 2009;2(1):5-12.
73. Raulji DM, Kamath KSS, Nayak NS, Pandya AS, Shabaraya AR: Effect of natural superdisintegrants on the fast dissolving tablet of carvedilol by sublimation method. Am J PharmTech Res 2013;3(5):258-270.
74. Sammour OA, Hammad MA, Megrab NA, Zidan AS. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion. AAPS Pharm Sci Tech, 2006;7(2):1-9.
75. Saroha K, Mathur P, Verma S, Syan N, Kumar A. Mouth dissolving tablets: An overview on future compaction in oral formulation technologies. Der Pharma Sinica, 2010;1(1):179-187.
76. Sastry SV, Nyshadham JR, Fix JA. Recent technological advances in oral drug delivery. A review. Pharm Sci Technol Today, 2000;3(4):138-145.
77. Sharma K, Pfister WR, Ghosh TK. Quick-dispersing oral drug delivery systems. In: Ghosh TK, Pfister WR, eds. Drug Delivery to the Oral Cavity: Molecules to Market. New York: CRC Press; 2005.p.261-90.
78. Shoukri RA, Ahmed IS, Shamma RN. In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets. Eur J Pharm Biopharm, 2009;73(1):162-171.
79. Shukla D, Chakraborty S, Singh S, Mishra B. Mouth dissolving tablets I: An overview of formulation technology. Sci Pharm, 2009;76:309-326.
80. Siden R, Wolf M. Disintegration of chemotherapy tablets for oral administration in patients with swallowing difficulties. J Oncol Pharm Pract, 2013;19(2):145-150.
81. Skulj V, Sirca J, Osel MJ. Rapidly disintegrating tablet. US Patent Application 20120028949:2012.
82. Thakur RR, Narwal S. Orally disintegrating preparations: recent advancement in formulation and technology. J Drug Deliv Therapeutics, 2012;2(3):87-96.
83. US FDA-Food and Drug Administration, CDER Data Standards Manual; 2003.
84. Vani R, Rasheed A. Formulation and evaluation of hydrochlorothiazide and ramipril mouth dissolving tablet using different superdisintegrants. IJPSR, 2014; Vol. 5(1): 207-212.
85. Wagh MA, Dilip KP, Salunkhe KS, Chavan NV, Daga VR. Techniques used in orally disintegrating drug delivery system. Int J Drug Deliv, 2010;2:98-107.
86. Wahren R, Skjaevestad B. Coated effervescent tablet. EP 2595609 A1: 2013.
87. Zhou H, Herron J, Liu Y, Lee P, Pesco-Koplowitz L. A new rapidly disintegrating formulation of cisapride is bioequivalent to standard cisapride tablets in the elderly. Clin Drug Invest, 1997;14(6):487-493.